AVAFORCE 200

What is AVAFORCE 200?

AVAFORCE 200 is a medicinal drug belonging to the pharmacological group of phosphodiesterase type 5 (PDE-5) inhibitors. Its main purpose is to restore erectile function in men who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual intercourse. The medication is manufactured in the form of oral tablets with an active ingredient dosage of 200 mg. The manufacturer of AVAFORCE 200 is the pharmaceutical company Centurion Laboratories, which specializes in producing high-quality drugs for improving men's health.

The active ingredient of AVAFORCE 200 is avanafil, a modern second-generation selective PDE-5 inhibitor. Unlike its predecessors, avanafil is distinguished by a faster onset of therapeutic action and a more favorable tolerability profile. The mechanism of action of the drug is based on relaxing the vascular smooth muscle of the penis, which increases arterial blood inflow during sexual stimulation. Due to this, a natural physiological erection is achieved, which occurs only in the presence of sexual arousal.

It is important to understand that AVAFORCE 200 is not a hormonal product and does not directly affect libido. The medication does not cause a spontaneous erection without sexual stimulation, making its application as physiological as possible. The high bioavailability of avanafil allows reaching therapeutic plasma concentrations within 15–30 minutes after intake. This enables patients to plan sexual activity without a long wait, significantly improving the quality of their intimate life.

What is AVAFORCE 200 Prescribed For?

The main indication for the use of AVAFORCE 200 is erectile dysfunction of various origins. This can be a psychogenic form related to stress, anxiety, or depressive states, as well as an organic one caused by vascular, neurological, or endocrine disorders. The drug is effective in patients with diabetes mellitus, arterial hypertension, and after surgical interventions on the pelvic organs. Clinical studies confirm the high efficacy of avanafil even in complex cases where other PDE-5 inhibitors proved to be insufficiently effective.

AVAFORCE 200 is also used to improve erection quality in men without an established diagnosis, but with episodic difficulties in the intimate sphere. The medication helps shorten recovery time between sexual acts and increase self-confidence. Thanks to its rapid onset of action, it is convenient to use on demand, without the need for long-term course administration. This is especially relevant for men leading an active lifestyle who value spontaneity in relationships.

Separately, it is worth noting the use of AVAFORCE 200 as part of complex therapy for psychogenic erectile dysfunction. Combined with psychotherapeutic support, the drug allows breaking the vicious cycle of failures, where the fear of failure itself blocks erection. Successful sexual intercourse while taking avanafil restores the patient's confidence, which over time can reduce the need for pharmacological support. Such an approach corresponds to modern principles of treating sexual disorders.

Composition and Active Components of AVAFORCE 200

Each AVAFORCE 200 tablet contains 200 mg of avanafil, a potent selective inhibitor of phosphodiesterase type 5. Avanafil blocks the PDE-5 enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the cavernous bodies of the penis. Increased cGMP levels lead to smooth muscle relaxation of the vessels, increased blood filling, and the occurrence of a stable erection. The selectivity of avanafil for PDE-5 significantly exceeds its affinity for other enzyme isoforms, minimizing the risk of systemic side effects.

Auxiliary components of AVAFORCE 200 include mannitol, starch, hydroxypropyl cellulose, magnesium stearate, and other pharmaceutically neutral substances. They ensure tablet stability, uniform release of the active substance, and proper bioavailability. The manufacturer Centurion Laboratories adheres to GMP standards, guaranteeing the consistent quality of every batch of the drug. The composition is selected to minimize irritation of the gastrointestinal mucosa and ensure rapid absorption.

The pharmacokinetics of avanafil is characterized by a rapid attainment of maximum plasma concentration—approximately 30–45 minutes after ingestion. The elimination half-life is about 5 hours, ensuring a sufficient duration of therapeutic effect without excessive accumulation in the body. Metabolism occurs predominantly in the liver with the participation of cytochrome P450 system enzymes, particularly the CYP3A4 isoenzyme. Excretion of metabolites is carried out mainly with feces and to a lesser extent with urine.

Dosage of AVAFORCE 200

The standard recommended dose of AVAFORCE 200 is one 200 mg tablet taken 15–30 minutes before planned sexual activity. The drug can be taken regardless of food intake, as high-fat meals do not significantly affect the rate and extent of avanafil absorption. The maximum recommended dosing frequency is once daily. Exceeding the specified dose does not lead to an increased effect, but significantly raises the risk of developing adverse reactions.

For elderly patients, dosage adjustment is usually not required; however, a possible decline in liver and kidney function should be considered. In cases of moderate hepatic impairment, the recommended starting dose may be reduced to 100 mg. For patients with severe hepatic or renal impairment, the use of AVAFORCE 200 is not recommended due to a lack of sufficient safety data. When co-administered with potent CYP3A4 inhibitors, the dose of avanafil should be reduced.

The duration of AVAFORCE 200 use is not limited in time, as the drug is used on demand rather than as a course of treatment. However, before starting regular use, it is necessary to undergo a medical examination to rule out hidden cardiovascular diseases. A doctor may recommend starting with a lower dose to assess individual tolerability. Increasing the dose on one's own without consulting a specialist is strictly prohibited.

How to Take AVAFORCE 200 Correctly?

The AVAFORCE 200 tablet should be taken orally with a sufficient amount of water, without chewing or crushing it. The optimal time of administration is 15–30 minutes before expected sexual contact, although the therapeutic effect can last up to 4–6 hours. The drug can be taken both on an empty stomach and after meals, which favorably distinguishes it from some other PDE-5 inhibitors. It is important to remember that sexual stimulation is required for the onset of action, as the drug does not cause an erection on its own.

In case of a missed dose of AVAFORCE 200, do not double the dose next time. The medication is used situationally, so a missed dose has no clinical significance—it is sufficient to take a tablet before the next planned sexual act. It is not recommended to take AVAFORCE 200 more often than once every 24 hours. If the effect of the application is insufficient, it is necessary to consult a doctor to adjust the therapy, rather than independently increasing the dosage.

While taking AVAFORCE 200, excessive consumption of grapefruit juice should be avoided, as it can affect the metabolism of the drug. It is also important to inform your doctor about all medications taken regularly, especially nitrates and nitric oxide donors. Patients with cardiovascular diseases require a cardiac risk assessment prior to starting use. Any doubts regarding the safety of administration should be discussed with a qualified specialist.

Side Effects of AVAFORCE 200

The most common side effects of AVAFORCE 200 are headache, flushing, nasal congestion, and back pain. These symptoms are usually mild to moderate in severity and resolve spontaneously within a few hours. Headache occurs as a result of vasodilation of cerebral vessels, while nasal congestion is due to effects on the mucosal vessels. The frequency of developing adverse reactions depends on individual patient sensitivity and the dose of the drug.

Uncommon side effects include dizziness, dyspeptic disorders, nausea, palpitations, and increased fatigue. Rarely, visual impairment, changes in color perception, tinnitus, or prolonged erection may be observed. Special attention should be paid to priapism—a painful erection lasting more than 4 hours, which requires immediate medical assistance. Sudden decreases in vision or hearing also require immediate medical attention.

The individual body response to AVAFORCE 200 may vary depending on age, concomitant diseases, and concomitant medication intake. In most cases, side effects are transient and do not require discontinuation of the drug. However, in the event of recurrent or severe adverse events, intake should be stopped and a physician consulted. Self-treatment and ignoring serious symptoms can lead to complications.

Contraindications of AVAFORCE 200

An absolute contraindication to the use of AVAFORCE 200 is the concomitant use of nitrates or nitric oxide donors in any form. This combination can cause a critical drop in blood pressure with the development of collapse or myocardial infarction. The drug is also prohibited for patients with hypersensitivity to avanafil or any excipient. Severe hepatic impairment, end-stage renal disease, and conditions under which sexual activity is not recommended are contraindications.

AVAFORCE 200 is prescribed with caution to patients with cardiovascular diseases, including unstable angina, recent myocardial infarction, or stroke. Anatomical deformations of the penis, such as Peyronie's disease, as well as conditions that increase the risk of priapism, require special caution. For patients with retinitis pigmentosa or optic neuritis, the drug is prescribed only after a thorough benefit-risk assessment.

AVAFORCE 200 is not intended for use in women, children, and adolescents under 18 years of age. Safety studies of the drug in these groups have not been conducted. Elderly men may be prescribed the drug without dose adjustment, but considering their overall health status and concomitant therapy. Prior to starting AVAFORCE 200, a physician consultation is mandatory to exclude hidden contraindications and assess individual risk.

Interaction of AVAFORCE 200 with Other Medicines and Alcohol

The most dangerous interaction of AVAFORCE 200 is with nitrates used for the treatment of angina, and with nitric oxide donors. Concomitant intake can lead to a sharp drop in blood pressure, which is life-threatening. Potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and ritonavir, can increase the plasma concentration of avanafil; therefore, when using them, the dose of AVAFORCE 200 should be reduced. Alpha-blockers used for prostatic hyperplasia also require cautious combination due to the risk of hypotension.

Alcohol in moderate amounts does not enter into a direct pharmacokinetic interaction with avanafil; however, its excessive consumption can worsen erectile function and increase the risk of side effects. While taking AVAFORCE 200, it is recommended to limit alcohol consumption to minimal doses. The drug usually does not affect the ability to drive vehicles, but if dizziness or visual disturbances occur, one should refrain from driving. Always inform your doctor about all medicines you are taking, including over-the-counter and herbal remedies.

Where to Buy AVAFORCE 200 in Ukraine

AVAFORCE 200 is available in Ukraine through pharmacy chains and specialized online platforms selling men's health products. The drug is available by prescription, so it is necessary to obtain an appropriate prescription prior to purchase. Tablets should be stored in a dry place, protected from light, at a temperature not exceeding 25 degrees Celsius. The shelf life is usually 24 months from the manufacturing date, after which the use of the drug is prohibited.

When purchasing AVAFORCE 200, it is important to check the integrity of the packaging and the presence of protective elements confirming the authenticity of Centurion Laboratories products. Delivery conditions for online orders must comply with drug storage requirements. Before first use, carefully read the instructions, and if you have any questions, consult a doctor or pharmacist. Remember that self-treatment can be dangerous, so a responsible approach to therapy is the key to safety and effectiveness.